Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

454.00
-4.0500-0.88%
Post-market: 457.833.83+0.84%19:57 EDT
Volume:2.20M
Turnover:1.00B
Market Cap:115.19B
PE:29.63
High:461.05
Open:454.62
Low:452.89
Close:458.05
52wk High:513.98
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.61
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.17
PE(LYR):29.63

Loading ...

Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Nov 20, 2020

Major Issues Report

8-K - Current report
Oct 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Sep 21, 2020

Major Issues Report

8-K - Current report
Sep 03, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 31, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
May 01, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 29, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 01, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2020

Major Issues Report

Current report, items 2.02 and 9.01